Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (NOSARSCOVID)

Clinical Trial ID NCT04290871

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04290871

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 10.13
2 A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020 7.78
3 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
4 Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020 1.38
5 Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis 2004 0.82
6 Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. Int J Infect Dis 2004 0.78
Next 100